Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

<p>Fusion status prediction from H&E images. <b>A,</b> Workflow for deep learning of normal tissue, FN-RMS, and FP-RMS. <b>B</b> and <b>C,</b> Representative (<b>B</b>) H&E images and (<b>C</b>) class activation maps as predic...

Бүрэн тодорхойлолт

-д хадгалсан:

Номзүйн дэлгэрэнгүй
Үндсэн зохиолч:	David Milewski (15050643) (author)
Бусад зохиолчид:	Hyun Jung (15050646) (author), G. Thomas Brown (15050649) (author), Yanling Liu (15050652) (author), Ben Somerville (15050655) (author), Curtis Lisle (15050658) (author), Marc Ladanyi (15050661) (author), Erin R. Rudzinski (15050664) (author), Hyoyoung Choo-Wosoba (15050667) (author), Donald A. Barkauskas (15050670) (author), Tammy Lo (15050673) (author), David Hall (15050676) (author), Corinne M. Linardic (15050679) (author), Jun S. Wei (14955721) (author), Hsien-Chao Chou (14955718) (author), Stephen X. Skapek (15050682) (author), Rajkumar Venkatramani (15050685) (author), Peter K. Bode (15050688) (author), Seth M. Steinberg (15043179) (author), George Zaki (15050691) (author), Igor B. Kuznetsov (15050694) (author), Douglas S. Hawkins (15050697) (author), Jack F. Shern (14938001) (author), Jack Collins (15050700) (author), Javed Khan (15046967) (author)
Хэвлэсэн:	2025
Нөхцлүүд:	Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Prognostic biomarkers Computational Methods Artificial intelligence & machine learning Pediatric Cancers Sarcomas Soft-tissue sarcoma
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

Ижил төстэй зүйлс

Figure 1 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
-н: David Milewski (15050643)
Хэвлэсэн: (2025)

Figure 3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
-н: David Milewski (15050643)
Хэвлэсэн: (2025)

Figure 4 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
-н: David Milewski (15050643)
Хэвлэсэн: (2025)

Figure 5 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
-н: David Milewski (15050643)
Хэвлэсэн: (2025)

Figure 6 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
-н: David Milewski (15050643)
Хэвлэсэн: (2025)

Supplementary Table S1-S3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
-н: David Milewski (15050643)
Хэвлэсэн: (2025)

Supplementary Tables S1-S5 from Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era
-н: Josephine K. Dermawan (17079555)
Хэвлэсэн: (2025)

Supplementary Data 1 from Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA Analysis
-н: Nam Q. Bui (14958210)
Хэвлэсэн: (2025)

Supplementary Table S3 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
-н: Caleb N. Seavey (15056489)
Хэвлэсэн: (2025)

Supplementary Table S4 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
-н: Caleb N. Seavey (15056489)
Хэвлэсэн: (2025)

Supplementary Dataset S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
-н: Srivandana Akshintala (16610490)
Хэвлэсэн: (2025)

Supplementary Table S5 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
-н: Srivandana Akshintala (16610490)
Хэвлэсэн: (2025)

Supplementary File 1 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
-н: Michael P. Ludwig (16721187)
Хэвлэсэн: (2025)

Supplementary File 2 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
-н: Michael P. Ludwig (16721187)
Хэвлэсэн: (2025)

Supplementary File 3 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
-н: Michael P. Ludwig (16721187)
Хэвлэсэн: (2025)

Supplementary File 4 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
-н: Michael P. Ludwig (16721187)
Хэвлэсэн: (2025)

Supplementary File 5 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
-н: Michael P. Ludwig (16721187)
Хэвлэсэн: (2025)

Supplementary File 6 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
-н: Michael P. Ludwig (16721187)
Хэвлэсэн: (2025)

Supplementary File 7 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
-н: Michael P. Ludwig (16721187)
Хэвлэсэн: (2025)

Supplementary File 8 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
-н: Michael P. Ludwig (16721187)
Хэвлэсэн: (2025)

Supplementary Figure 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
-н: Tom Wei-Wu Chen (15053003)
Хэвлэсэн: (2025)

Supplementary Figure 2 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
-н: Tom Wei-Wu Chen (15053003)
Хэвлэсэн: (2025)

Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
-н: Tom Wei-Wu Chen (15053003)
Хэвлэсэн: (2025)

Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
-н: Tom Wei-Wu Chen (15053003)
Хэвлэсэн: (2025)

Supplementary Table 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
-н: Tom Wei-Wu Chen (15053003)
Хэвлэсэн: (2025)

Figure S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
-н: Upendra Kumar Soni (15051683)
Хэвлэсэн: (2025)

Figure S2 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
-н: Upendra Kumar Soni (15051683)
Хэвлэсэн: (2025)

Figure S3 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
-н: Upendra Kumar Soni (15051683)
Хэвлэсэн: (2025)

Figure S4 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
-н: Upendra Kumar Soni (15051683)
Хэвлэсэн: (2025)

Figure S5 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
-н: Upendra Kumar Soni (15051683)
Хэвлэсэн: (2025)

Figure S6 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
-н: Upendra Kumar Soni (15051683)
Хэвлэсэн: (2025)

Supplementary Data File S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
-н: Upendra Kumar Soni (15051683)
Хэвлэсэн: (2025)

Supplementary Tables from Targeting BCL6 in Gastrointestinal Stromal Tumor Promotes p53-Mediated Apoptosis to Enhance the Antitumor Activity of Imatinib
-н: Xiangyu Zeng (17314920)
Хэвлэсэн: (2025)

Video 1_Imaging-driven diagnosis of retroperitoneal psoas major alveolar soft part sarcoma: a case report.mp4
-н: Shasha Wei (1555588)
Хэвлэсэн: (2025)

TableS1 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
-н: Tingting Liu (15386915)
Хэвлэсэн: (2025)

TableS2 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
-н: Tingting Liu (15386915)
Хэвлэсэн: (2025)

TableS3 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
-н: Tingting Liu (15386915)
Хэвлэсэн: (2025)

TableS4 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
-н: Tingting Liu (15386915)
Хэвлэсэн: (2025)

TableS5 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
-н: Tingting Liu (15386915)
Хэвлэсэн: (2025)

Supplementary Table S1 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
-н: Dongliang Leng (17079663)
Хэвлэсэн: (2025)

Cannot write session to /tmp/vufind_sessions/sess_4vr47li1ugr8k9v6ajq7d70ero